Model for end-stage liver disease (MELD) exception for polycystic liver disease

Systematic review: the pathophysiology and management of polycystic liver disease

“…In addition, untreatable complications due to presinusoidal portal hypertension (i.e. ascites, variceal bleeding), functional Budd‐Chiary‐like syndrome are also part of the MELD exception criteria for LT (Eurotransplant) 85 . A significant proportion (42%) of the procedures consists of combined liver and kidney transplants 61 .…”

Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula

“…Polycystic liver disease rarely carries an increased mortality risk, although these patients can have severe deterioration in their quality of life 11. There are many nontransplant options that may temporarily or rarely, permanently, relieve symptoms.…”

Development and validation of a polycystic liver disease complaint-specific assessment (POLCA)

“…The mid-upper arm circumference is currently used as a gold standard to assess malnutrition as it reflects lean body mass. However, other more objective techniques should be evaluated in the future such as the calculation of total muscle mass at lumbar 3 level to assess the prevalence of sarcopenia and identify PCLD specific risk factors for poor nutrition complementary to the POLCA [35,36]. Finally, although validity was tested in a comprehensive way, other hypotheses could have been considered.…”